Evidence that HDAC7 acts as an epigenetic "reader" of AR acetylation through NCoR-HDAC3 dissociation

Cell Chem Biol. 2022 Jul 21;29(7):1162-1173.e5. doi: 10.1016/j.chembiol.2022.05.008. Epub 2022 Jun 15.

Abstract

Histone deacetylase (HDAC) proteins are epigenetic regulators that govern a wide variety of cellular events. With a role in cancer formation, HDAC inhibitors have emerged as anti-cancer therapeutics. Among the eleven metal-dependent class I, II, and IV HDAC proteins targeted by inhibitor drugs, class IIa HDAC4, -5, -7, and -9 harbor low deacetylase activity and are hypothesized to be "reader" proteins, which bind to post-translationally acetylated lysine. However, evidence linking acetyllysine binding to a downstream functional event is lacking. Here, we report for the first time that HDAC4, -5, and -7 dissociated from corepressor NCoR in the presence of an acetyllysine-containing peptide, consistent with reader function. Documenting the biological consequences of this possible reader function, mutation of a critical acetylation site regulated androgen receptor (AR) transcriptional activation function through HDAC7-NCoR-HDAC3 dissociation. The data document the first evidence consistent with epigenetic-reader functions of class IIa HDAC proteins.

Keywords: HDAC7; NCoR; androgen receptor; epigenetic reader; histone deacetylase.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Epigenesis, Genetic
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylases* / metabolism
  • Receptors, Androgen* / genetics
  • Receptors, Androgen* / metabolism

Substances

  • Histone Deacetylase Inhibitors
  • Receptors, Androgen
  • Histone Deacetylases